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Background: In recent years, palliative care utilization has been increasing while lifesustaining/local procedures have been declining at the end of life. Palliative care utilization
widely varies based on tumor type. Limited information is available on inpatient palliative
care in colorectal cancer.
Aims: This study investigated inpatient palliative care utilization and its association with
patient demographics, hospital charges, and procedures among colorectal cancer patients
admitted to US hospitals between 2008 and 2017. Receipt of life-sustaining and local
procedures and surgeries were also investigated during the ten years.
Methods: Data were extracted from the National inpatient sample (NIS) database containing
de-identified information from each hospitalization. Codes V66.7 for ICD-9-CM or Z51.5 for
ICD-10-CM were used to find palliative care utilization. Data were analyzed using general
ized regression with adjustment for variations in predictors. The Compound Annual Growth
Rate (CAGR) was calculated for palliative care and procedures over time.
Results: Of the 487,027 colorectal cancer hospitalizations, only 6.04% utilized palliative
care. This percentage significantly increased over time from 2.3% in 2008 to 9.3% in 2017
(P<0.0001). Palliative care utilization sizably decreased hospital charges by $18,010 per
hospitalization (P<0.0001) and was positively associated with female gender, severe disease,
and age over 80 years (P≤ 0.05). Palliative care utilization was inversely associated with
using life-sustaining and local procedures and surgeries (P<0.0001). Life-sustaining proce
dures (intubation, infusion of concentrate nutrients, dialysis, and blood transfusion) and
surgeries were decreased over time (P<0.001).
Conclusions: Palliative care utilization increased over time and was inversely associated
with hospital charges and performing procedures among colorectal cancer patients. Our
findings warrant further research and interventions to increase palliative care utilization in
colorectal cancer.
Keywords: colorectal cancer, financial burden, hospital charges, palliative care, procedures,
public health

Introduction
Palliative care provides comfort and improves the quality of life for patients dealing
with terminal illnesses, ideally throughout the course of the disease. The palliative
care team consists of physicians, nurses, social workers, and other specialties
working together to alleviate pain as well as psychological and spiritual distress
of patients with terminal illnesses.1–5 This symptom management has been asso
ciated with a reduction in non-beneficial procedures and also hospital charges and
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length of stay (LOS).1–5 The utilization of palliative care
mainly varies by gender, race/ethnicity, educational level,
obesity, socioeconomic status, health insurance type, and
discussion by physicians in the last year of life.6–11
Additionally, palliative care usage varies widely based on
tumor type,12 indicating that each cancer needs to be
investigated in order to identify appropriate interventions
for promoting palliative care where it is underutilized.
Colon cancer has been on the rise in recent decades
across the world. In the USA, it is the third most
common cancer in both men and women. Generally,
if colon cancer is diagnosed early, the tumor can be
removed by surgery, with a 5-year survival of up to
60%.13 However, end-stage colorectal cancer patients
suffer from obstruction and colostomy in addition to
other distressful symptoms. Fear of leakage, embarrass
ment caused by noises, gas, and odor, need for
increased privacy can lead to social isolation, depres
sion, and anxiety.14,15 These patients can thus be
appropriate candidates for palliative care to improve
their quality of life.
A nationally representative database in the USA is
the national inpatient sample (NIS).6–8 The NIS dataset
also facilitates reliable comparisons across studies.
Using the NIS dataset, it has been revealed that pallia
tive care utilization has increased in recent decades in
the USA, but varies widely based on tumor type, with
documented utilization ranging from 4.9% in breast
cancer hospitalizations to 16% in liver cancer
hospitalizations.12 The underlying reasons for such var
iations have not been fully explained, but the variations
may be related to differences in prognosis, distressful
symptoms, or patient demographics. Previous research
found a 5% utilization of inpatient palliative care for
colorectal cancer patients between 2004 and 2016.12
However, data are not available in detail to provide
insight about demographics, dying status, gender, etc.
of the patients.
In the current study, using V66.7 (ICD-9, before
Oct 2015) and Z51.5 (ICD-10, after Oct 2015) codes
within the NIS database, we aimed to characterize the
extent of utilization of inpatient palliative care services
among colorectal cancer patients and its association with
gender, age, race/ethnicity, hospital charges, payer source,
the severity of disease, life-sustaining, and local proce
dures, and surgery. Temporal trends of palliative care and
procedures were also determined for the study period.
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Methods
Study Design
A pooled, retrospective, cross-sectional study was con
ducted based on hospital discharge data retrieved from
the NIS, a database that is part of the Healthcare charge
and Utilization Project (HCUP). The NIS is a secondary
dataset and contains data from over seven million hospital
stays each year in the USA. It represents a 20% sample
from hospital stays.
Our research was conducted in accordance with the
Declaration of Helsinki. Upon completion of a data user
agreement with the Agency for Healthcare Research and
Quality, the sponsoring agency for HCUP, completely deidentified data was delivered. Therefore, the NIS data are
interpretable for each hospitalization, and possible read
mitted cases are considered new hospitalization. The
Institutional Review Board at the University of Nevada,
Las Vegas found the current study to be exempt with
negligible risks to subjects.

Study Population and Variables
The study period was from 2008 to 2017. International
Classification of Diseases, 9th revision, Clinical
Modification (ICD-9-CM) and ICD-10.CM codes were
used to identify colorectal cancer (Supplementary File 1).
Hospitalizations with ICD-9 or ICD-10 codes for color
ectal cancer were included. Patients younger than 18 years
or missing demographic data were excluded. Extracted
variables of interest for each hospitalization included age
group (<30 years old, 40–49, 50–59, 60–69, 70–79, and
≥80 years old), gender, race, quartile of median income by
zip codes, the severity of illness (All Patient Refined
Diagnosis-Related Group [APR-DRG]), primary payer
(Medicare, Medicaid, private insurance, other), the number
of diagnoses/comorbidities, metastasis, LOS, in-hospital
death, hospital size, hospital locations and regions, hospi
tal charges, local procedure (endoscopy, stent insertion,
and drainage), life-sustaining procedures (intubation, infu
sion, infusion of concentrate nutrients, dialysis, blood
transfusion, and cardiopulmonary resuscitation [CPR]),
and surgeries (resection, bypass, and colostomy creation).
APR-DRG has four levels of 1 to 4, indicating minor,
moderate, major, and extreme loss of function. ICD9-CM and ICD-10.CM codes used to extract palliative
care and procedures are shown in Supplementary File 1.
Patients, at discharge, are coded for palliative care in the
NIS database when terms such as palliative care, comfort
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care, end-of-life care, hospice, or similar terms are written
in their records.6–8 Therefore, these codes cover a range of
palliative care services from consultation to full services.
Total hospital charges were adjusted for the annual hospi
tal expenditure growth rate provided by the Center for
Medicare and Medicaid Services each year.6,16,17

Statistical Analyses
Generalized regression analysis with patient characteristics
as the individual level and hospital characteristics as the
hospital level was conducted, with adjustment for varia
tions in predictors. The hospital was the random effect in
the generalized modeling to control for the potential
within-hospital clustering effects; with other variables
being included as the fixed effects. The link function was
Logit. The main outcomes were receipt of palliative care,
palliative procedures, and hospital charges, and death dur
ing hospitalization. All covariates were categorical except
for three ordinal variables, age group (1–7), APR-DRG
Severity score (1–4), and quartiles of median income by
zip code (1–4). Odds ratios (ORs) and their corresponding
95% confidence intervals (CIs) were computed for predic
tors. The compound annual growth rate (CAGR) was
calculated using Excel software to calculate temporal
trends. The formula for CAGR is (y/x),1/(B-A)-1
where year A is x and year B is y. The statistical signifi
cance of CAGR was tested using Rao-Scott correction for
χ2 tests for categorical variables.6 All reported P-values
were 2-tailed; P-values < 0.05 were considered statistically
significant.

Results
Totally, 487, 027 colorectal cancer hospitalizations with
complete data constitute our study group. Their characteris
tics are demonstrated in Table 1. The mean age was 66.5 ±
13.9 years, and men comprised 52% of our study population.
As the median household income increased, the colorectal
cancer rate also increased (21.7% in the lowest percentile of
income and 28.2% in the highest percentile of income).
Inpatient palliative care was utilized by 6.7% of patients
(Table 1). The majority of patients were white (71.7%), had
Medicare (55.5%), were admitted to large hospitals (59.6%)
located in rural areas (55.8%) and the South (38.9%).
The CAGRs of intubation, infusion, infusion of con
centrate nutrients, dialysis, blood transfusion, and CPR
were −2.30%, 12.27% −5.21%, −11.53%, −5.28%, and
−0.76%, respectively. Intubation, infusion, infusion of
concentrate nutrients, dialysis, and blood transfusion
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significantly changed over time (P<0.001), but CPR
remained unchanged (P=0.198). Figure 1 presents the
CAGRs of pooled life-sustaining procedures, local proce
dures, surgeries, and palliative care with CAGRs of −3.9%
(P<0.001), 0.31% (P=0.015), −0.62% (P<0.001), and
14.9% (P<0.001), respectively. All were significantly
changed over time (P<0.05).
Palliative care utilization significantly increased over
time (OR= 1.09, CI= 1.08–1.10, P<0.0001). As the age
increased, the odd of receiving palliative care increased by
22% (OR=1.22, CI= 1.21–1.24, P<0.0001). Other Factors
associated with a higher receipt of palliative care included
female gender (OR=1.17, CI= 1.14–1.20, P<0.0001),
black race compared to whites (OR=1.10, CI= 1.06–1.15,
P<0.0001), Hispanics compared to whites (OR=1.05, CI=
1.00–1.11, P=0.0350), Asians/ Pacific Islanders (PI) com
pared to whites (OR=1.18, CI= 1.10–1.27, P<0.0001),
disease severity (OR=1.80 as the severity increased one
level higher, CI= 1.77–1.84, P< 0.0001), metastasis
(OR=2.31, CI= 2.25–2.37, P< 0.0001), and uninsured
patients (OR=1.31 as compared to patients with private
insurance, CI= 1.21–1.42, P< 0.0001). Medicare benefici
aries significantly used less palliative care services com
pared to patients with private insurance (OR= 0.67, CI=
0.65–0.69, P< 0.0001).
Life-sustaining procedures, local procedures, surgeries,
small and medium hospitals compared to large hospitals,
and rural and urban non-teaching hospitals compared to
urban-teaching hospitals all were significantly associated
with lower palliative care utilization (P< 0.0001). The
quartile of median income was not associated with pallia
tive care utilization (P=0.2851) (Table 2).
As it is indicated in Table 3, local procedures signifi
cantly decreased over time and their utilization was sig
nificantly lower in women than in men and blacks and
Hispanics than in whites (P< 0.05). Asians/ PI signifi
cantly utilized more local procedures than whites (P<
0.0001). Patients with Medicare, Medicaid, no insurance,
and no charges, compared to private insurance, and metas
tasis significantly had lower utilization of local procedures
(P< 0.0001). The severity of illness, number of diagnoses/
comorbidities, and higher quartile of median income were
significantly associated with higher utilization of local
procedures (P< 0.0001). Small and medium hospitals com
pared to large hospitals, rural and urban nonteaching hos
pitals compared to urban-teaching hospitals, and hospitals
in Midwest compared to the South had significantly lower
utilization of local procedures (P< 0.05).
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Table 1 Characteristics of Colorectal Cancer Patients (The NIS Dataset; Weighted Number, 2,478,432)
Characteristics

2008–2017

2008

2011

2014

2017

52.0 (1,290,235)

51.2 (133,291)

51.3 (129,571)

52.0 (122,475)

52.8 (127,785)

48.0 (1,186,526)

48.7 (126,974)

48.6 (122,719)

47.9 (112,880)

47.1 (114,035)

66.5 (31.1)

67.6 (31.3)

67.1 (30.8)

66.2 (31.0)

65.8 (31.0)

<30

0.6 (16,292)

0.6 (1667)

0.6 (1583)

0.6 (1519)

0.7 (1614)

30–39
40–49

2.5 (63,278)
8.4 (208,178)

2.3 (6001)
8.0 (21,012)

2.3 (5835)
8.0 (20,403)

2.6 (6194)
8.3 (19,680)

2.7 (6740)
8.4 (20,409)

50–59

19.5 (484,084)

17.9 (46,824)

19.1 (48,440)

20.1 (47,435)

19.8 (48,054)

60–69
70–79

25.0 (621,487)
23.6 (586,033)

23.1 (60,377)
24.8 (200,523)

24.2 (61,341)
23.9 (60,412)

25.5 (60,110)
23.3 (54,970)

26.5 (64,284)
23.6 (57,129)

≥80

20.1 (499,080)

23.0 (260,504)

21.5 (54,354)

19.3 (45,465)

18.0 (43,619)

71.7 (1,630,625)

74.0 (153,957)

72.3 (16,747)

72.5 (16,215)

70.1 (164,364)

13.4 (304,890)
8.3 (188,970)

12.0 (25,009)
7.2 (15,014)

14.2 (32,978)
7.9 (18,327)

12.9 (28,855)
8.4 (18,835)

13.1 (30,930)
9.3 (21,860)

Asian/Pacific Islander

3.1 (72,487)

3.1 (6549)

2.6 (6232)

3.2 (7195)

3.6 (8569)

Native Americans/others

0.5 (11,342)

0.4 (904)

0.4 (875)

0.4 (939)

0.5 (1150)

55.5 (1,373,744)
9.4 (234,412)

56.8 (148,053)
7.3 (18,989)

56.9 (14,343)
8.3 (21,071)

55.2 (129,660)
10.4 (24,420)

55.1 (133,085)
10.9 (26,364)

Gender % (n)
Male
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Female
Age, mean (SD)
Age groups % (n)

Race % (n)
White
Black
Hispanic

Payer source % (n)
Medicare
Medicaid
Private insurance

29.4 (728,593)

30.4 (79,211)

29.0 (73,105)

29.5 (69,260)

29.3 (70,914)

Uninsured
No charge

2.7 (68,872)
0.3 (8529)

2.1 (5510)
0.4 (1015)

2.7 (6956)
0.5 (1230)

2.3 (5540)
0.3 (724)

2.2 (5395)
0.2 (500)

Other

2.4 (60,036)

2.8 (7459)

2.4 (6138)

2.2 (5264)

2.1 (5209)

76th to 100th percentile

28.2 (684,373)

26.5 (68,978)

28.4 (71,658)

27.6 (64,965)

28.6 (69,155)

51st to 75th percentile
26th to 50th percentile

26.1 (633,419)
23.9 (581,025)

27.8 (72,579)
23.2 (60,489)

24.5 (61,931)
25.7 (65,029)

27.8 (65,350)
23.3 (43,790)

26.2 (63,529)
23.9 (57,894)

0th to 25th percentile

21.7 (526,711)

22.4 (58,447)

21.3 (53,907)

21.3 (50.160)

21.2 (51,234)

Median household income by zip code % (n)

Severity of illness % (n)
APR-DRG 1

14.1 (351,122)

14.9 (38,967)

13.7 (34,683)

13.6 (32,150)

12.4 (30,000)

APR-DRG 2
APR-DRG 3

39.9 (990,107)
34.5 (856,072)

42.0 (109,522)
32.6 (85,061)

38.1 (96,231)
35.4 (89,386)

39.5 (93,025)
35.8 (840.240)

37.6 (91,064)
36.9 (89,189)

APR-DRG 4

11.3 (281,129)

10.3 (26,953)

12.7 (32,249)

11.0 (25,960)

13.0 (31,564)

Metastasis % (n)

29.9 (742,485)

27.6 (71,944)

28.7 (72,463)

30.2 (71,210)

32.2 (78,024)

Palliative care consultation % (n)

6.0 (149,707)

2.3 (5998)

5.3 (13,374)

7.4 (17,630)

9.2 (22,440)

Life-sustaining procedures % (n)

24.1 (598,512)

26.4 (68,748)

27.6 (69,876)

24.0 (56,390)

17.0 (41,119)

Local procedures % (n)

10.1 (251,653)

19.0 (26,055)

10.6 (26,758)

10.9 (25,755)

10.6 (25,729)

Surgeries % (n)

36.6 (909,254)

45.6 (118,940)

45.4 (114,813)

44.4 (19,461)

36.2 (87,644)

Number of diagnoses/comorbidities, mean (SD)

11.7 (13.8)

9.6 (11.2)

11.1 (12.8)

12.6 (14.2)

13.9 (15.4)

LOS, mean (std.)

7.0 (16.0)

7.7 (16.9)

7.2 (17.0)

6.9 (15.2)

6.5 (15.0)

76,505 (218,107)

78,893 (223,242)

77,353 (225,263)

76,075 (211,823)

75,599 (215,997)

Total charges, mean $ (SD)

(Continued)
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Table 1 (Continued).
Characteristics

2008–2017

2008

2011

2014

2017

In-hospital death % (n)

4.4 (110,763)

5.0 (13,080)

4.5 (11,460)

4.2 (9900)

4.2 (10,164)

Hospital bed size % (n)
Small

14.4 (355,069)

11.8 (30.904)

11.4 (28,447)

17.7 (41,740)

17.5 (42,443)

25.9 (640,951)

23.1 (60,299)

24.3 (60,594)

28.0 (65,950)

28.6 (69,159)

59.6 (1,472,027)

64.9 (168,939)

64.2 (160,202)

54.2 (127,585)

53.8 (130,215)

Urban non-teaching
Urban teaching

10.9 (270,823)
33.1 (818,200)

12.7 (33,109)
42.4 (110,414)

11.4 (28,495)
40.4 (100,834)

9.7 (22,894)
24.8 (58,529)

8.6 (20,849)
20.9 (50,760)

Rural

55.8 (1379,023)

44.8 (116,619)

48.1 (119,914)

65.4 (153,950)

70.4 (170,209)

Northeast

19.7 (488,873)

18.9 (49,352)

19.8 (20,125)

19.3 (45,550)

19.0 (46,164)

Midwest
South

23.1 (574,131)
38.9 (964,613)

23.9 (62,414)
39.2 (102,128)

22.8 (57,713)
39.9 (100,885)

22.8 (53,859)
39.3 (92,476)

22.5 (54,499)
39.0 (94,440)

West

18.1 (450,813)

17.8 (46,609)

17.3 (43,826)

18.4 (43,489)

19.3 (46,714)

Medium
Large
Hospital location/teaching status % (n)

Hospital region

Abbreviations: NIS, National Inpatient Sample; SD, standard deviation; APR-DRG, all-patient refined diagnosis-related group.

Table 4 displays factors associated with hospital charges
among colorectal cancer patients. Palliative care was asso
ciated with a reduction of $18,010 per hospitalization
(P<0.0001). A significant decrease in hospital charges over
time for colorectal cancer patients was observed after adjust
ment for the health inflation rate (P< 0.0001). Being a woman
compared to men was associated with reduced hospital
charges (P< 0.0001). Medicare and Medicaid beneficiaries
and uninsured patients had significantly lower hospital charges
compared to private insurance (P< 0.0001). Lower hospital

charges were significantly reported in small and medium
hospitals (as compared to large hospitals), rural and urban nonteaching hospitals (as compared to urban-teaching hospitals),
and Midwest hospitals (as compared to South hospitals) (P<
0.0001). Blacks, Hispanics, and Asians/PI Islanders had sig
nificantly higher hospital charges compared to whites (P<
0.0001). As the severity of the illness or the number of
diagnoses/comorbidities increased, hospital charges signifi
cantly increased (P< 0.001). In-hospital death, life-sustaining
procedures, local procedures, surgeries, higher quartiles of

Figure 1 Compound annual growth rates of pooled life-sustaining and local procedures, surgeries, and palliative care in colorectal cancer patients.
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Table 2 Factors Associated with Inpatient Palliative Care
Consultation in Colorectal Cancer (n = 487,027)
Independent Variable

OR

95% CI

P-value

Independent Variables

OR

95% CI

P-value

Year

1.09

1.08–1.10

<0.0001

Year

0.94

0.93–0.94

<0.0001

Age group

1.22

1.16–1.24

<0.0001

Age group

1.02

1.01–1.03

<0.0001

Female

1.17

1.14–1.20

<0.0001

Female

0.98

0.97–0.99

0.020

<0.0001

Race

Race

White (reference)

1.00

Black

0.95

0.93-0.0.97

Hispanic

0.90

0.88–0.0.92

<0.0001

<0.0001

Asian/Pacific Islander

1.10

1.06–1.14

<0.0001

0.4166

Other

0.99

0.96-0.1.00

0.8700

White (reference)

1.00

Black

1.10

1.06–1.15

<0.0001

Hispanic

1.05

1.00–1.11

0.035

Asian/Pacific Islander

1.18

1.10–1.27

Other

0.96

0.89–1.04

Primary payer

Primary payer

Private insurance (reference)

1.00

Private insurance (reference)

1.00

Medicare

0.67

0.65–0.69

<0.0001

Medicare

0.84

0.83–0.86

<0.0001

Medicaid

1.03

0.98–1.108

0.1698

Medicaid

0.66

0.64–0.67

<0.0001

Uninsured

1.31

1.21–1.42

<0.0001

Uninsured

0.82

0.79–0.85

<0.0001

No charge

0.71

0.53–0.95

0.0236

No charge

0.70

0.63–0.77

<0.0001

Other

2.58

2.41–2.76

<0.0001

Other

0.65

0.62–0.68

<0.0001

Severity of illness: APR-DRG

1.80

1.77–184

<0.0001

Severity of illness: APR-DRG

1.08

1.07–1.10

<0.0001

Metastasis

2.31

2.25–32.37

<0.0001

Metastasis

0.34

0.33–0.34

<0.0001

Number of diagnoses/comorbidities

1.06

1.06–1.07

<0.0001

Number of diagnoses/comorbidities

1.00

1.00–101

<0.0001

Life-sustaining procedures

0.89

0.86–0.92

<0.0001

In-hospital death

1.11

1.08–1.14

<0.0001

Local procedures

0.84

0.80–0.87

<0.0001

Quartile of median income by zip code

1.02

1.01–1.03

<0.0001

Surgeries

0.23

0.22–0.24

<0.0001

Hospital bed size

Quartile of median income by zip code

1.00

0.99–1.02

0.2851

Large (reference)

Hospital bed size
Large (reference)

1.00

Small

0.85

0.82–0.89

<0.0001

Medium

0.94

0.89–0.96

0.0029

Hospital location/teaching status
Urban teaching (reference)

1.00

Rural

0.79

0.75–0.84

<0.0001

Urban nonteaching

0.85

0.82–0.88

<0.0001

South (reference)

1.00

Northeast

1.07

1.00–1.13

0.0264

Midwest

0.95

0.90–1.01

0.1325

West

1.13

1.07–1.20

<0.0001

median income were significantly associated with higher hos
pital charges (P< 0.0001).

Discussion
We investigated temporal trends of palliative care utiliza
tion among colorectal cancer patients from 2007 to 2018.
We found that its usage increased over time, but utilization

https://doi.org/10.2147/CMAR.S330448

DovePress

0.83

0.81–0.85

<0.0001

Medium

0.97

0.950-0.0.99

0.0008

Urban teaching (reference)

1.00

Rural

0.74

0.73–0.76

<0.0001

Urban nonteaching

0.94

0.92–0.96

<0.0001

Hospital region

Hospital region

7574

1.00

Small

Hospital location/teaching status

Abbreviations: OR, odds ratio; CI, confidence interval; APR-DRG, all patient
refined-diagnosis-related group.
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Table 3 Factors Associated with Local Procedures in Colorectal
Cancer (n = 487,027)

South (reference)

1.00

Northeast

0.98

0.95-0.100

0.1359

Midwest

0.93

0.90–0.95

<0.0001

West

1.09

1.05–1.12

<0.0001

Abbreviations: OR, odds ratio; CI, confidence interval; APR-DRG, all patient
refined-diagnosis-related group.

of life-sustaining and surgeries were decreased. Palliative
care was also positively associated with reduced hospital
charges, female gender, older ages, the severity of illness,
metastasis, and the number of diagnoses/comorbidities.
Palliative care was inversely associated with lifesustaining and local procedures, surgeries, hospitalization
at small/medium hospitals compared to large hospitals,
and at rural/non-teaching urban hospitals compared to
urban-teaching hospitals.
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Table 4 Factors Associated with Hospital Charges in Colorectal
Cancer
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Independent Variable

Coefficient,

Standard

β

Error

P-value

Year

−1801

48

<0.0001

Age group

−3076

128

<0.0001

Female

−3883

262

<0.0001

Race
White (reference)

1.00

Black

2273

422

<0.0001

Hispanic

12,868

521

<0.0001

Asian/Pacific Islander

12,247

815

<0.0001

7888

780

<0.0001

Other
Primary payer
Private insurance (reference)

1.00

Medicare

−4485

370

<0.0001

Medicaid

−5602

501

<0.0001

Uninsured

−4657

826

<0.0001

No charge

−5993

2230

0.0072

−10,523

873

<0.0001

Severity of illness: APR-DRG

27,204

210

<0.0001

Metastasis

−29,263

298

<0.0001

Number of diagnoses/comorbidities

2263

30.

<0.0001

In-hospital death

8766

654

<0.0001

Palliative care

−18,010

560

<0.0001

Life-sustaining procedures

32,505

316

<0.0001

Local procedures

22,298

411

<0.0001

Surgeries

50,683

271

<0.0001

649

128

<0.0001

−10,306

386

<0.0001

−7117

310

<0.0001

−28,050

453

<0.0001

−3792

297

<0.0001

Other

Quartile of median income by zip
code
Hospital bed size
Large (reference)
Small
Medium

1.00

Hospital location/teaching status
Urban teaching (reference)
Rural
Urban nonteaching

1.00

Hospital region
South (reference)

1.00

Northeast

10,388

375

<0.0001

Midwest

−8653

355

<0.0001

West

28,907

398

<0.0001

Abbreviation: APR-DRG, All patient refined-diagnosis-related group.

Rubens et al investigated palliative care utilization in
overall common cancers, using the same dataset as ours,
between 2005 and 2014.12 They found the utilization of

Cancer Management and Research 2021:13

palliative care in colorectal cancer was 5%, which was
lower than the national average of 9.9% in cancer.12 Our
finding on colorectal cancer is 1.7% higher than theirs that
might be explained by more updated findings of the cur
rent study since palliative care utilization has been increas
ing in recent years.6–8,12,18–20 Health insurance policies are
increasingly promoting payments based on diagnosis
rather than traditional fee-for-services in the USA.16 This
might be an underlying reason for increasing palliative
care and decreasing non-beneficial life-sustaining proce
dures at the end of life, a finding that has been frequently
reported in a wide range of disorders from cancers to noncancer conditions in recent years.6–8,12,17,18 Improving
acceptance of the importance of palliative care services
and access to these services are other reasons for the
upward trend of palliative care utilization in recent
years.8 We found that the utilization of life-sustaining
procedures (intubation, infusion of concentrate nutrients,
dialysis, and blood transfusion) was reduced in the patients
over time. Interestingly, performing life-sustaining or local
procedures was negatively associated with palliative care
utilization, implying that these procedures might have
been conducted as an alternative to palliative care.
However, the palliative care team provides emotional sup
port and pain management and also determines the goal of
care,1–5 the services that are not delivered through other
procedures. Therefore, palliative care should be encour
aged even among patients undergoing life-sustaining and
local procedures. Surgery was conducted in almost 37% of
colorectal cancer patients during their admission and was
inversely and strongly associated with a reduction in pal
liative care utilization, implying that surgery was likely
curative, at least in some patients, with no need for pallia
tive care during that hospital stay.
The receipt of palliative care in colorectal cancer in our
study was very low compared to other cancers and was
close to previous reports on colorectal cancer,12 which
might be related to the overall good prognosis of the
disease. However, almost, 30% of our patients were meta
static and 46% had a moderate to severe loss of function
(APRDG 3 and 4). Colorectal cancer patients in advanced
stages can be appropriate candidates for palliative care due
to the distressful symptoms/conditions accompanied by the
disease, such as obstruction, pain, colostomy, odor, and
social isolation.14,15 There is a prominent non-profit orga
nization, the United Ostomy Associations of America, that
supports, empowers, educates, and advocates for
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improving the quality of care and life for patients with
a colostomy in the USA.15 Evidence indicates that this
society is very helpful for alleviating emotional pain
related to colostomy.15 The possibility that this society
can act as an alternative to palliative care during the course
of colorectal cancer, particularly when it is not close to
death, needs more investigations.
Palliative care was negatively associated with both hos
pital bed size and location in colorectal cancer. These asso
ciations have been reported in many previous studies,18,21–23
which indicate that the focus of palliative care promotion has
been on large urban-teaching hospitals. Emerging evidence
has demonstrated that a dedicated part-time palliative care
team can still reduce hospital charges and increase referrals
to home hospice in rural hospitals.21 Certain interventions
should be implemented to increase palliative care access in
small and rural hospitals in the USA.
Our study, for the first time, provides insight into
details of palliative care, and life-sustaining/local proce
dures among overall colorectal cancer patients in US hos
pitals. The utilization of palliative care was 6.9% while
almost 30% of our patients were metastatic and 46% had
a moderate to severe loss of function. Patients hospitalized
in smaller and rural/nonteaching hospitals received less
palliative care, which might be partly due to the unavail
ability of these services in those hospitals.8 Minorities did
not receive less palliative care in colorectal cancer that
contrasts with some other conditions.18 Palliative care
reduced hospital charges even after controlling for proce
dures and remained an independent factor for predicting
hospital charges. Although palliative care has increased
over time, it still seems underutilized in colorectal cancer.
Therefore, palliative care should be promoted in all races
in colorectal cancer, particularly in metastatic, advanced
stages, and small/rural hospitals.
Our study has limitations. We used codes to investigate
palliative care and procedures. Errors during the coding
process have been reported previously.24 However, these
errors can have minimal impact on the interpretation of
our results due to our large sample size. We could not
determine tumor stages since the NIS dataset does not
contain such information. The NIS dataset provides deidentified data and readmitted cases are considered new
admissions. Therefore, the NIS data are interpretable for
each hospitalization, not for a given patient throughout the
course of the disease. Almost 12% of our patients had
another diagnosis/comorbidity. The percentage increased
from 9.6% in 2008 to 13.9% in 2017, indicating these are
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mainly chronic illnesses in older people since chronic ill
nesses have been on the rise in the USA in recent
decades.25 However, there is still a possibility that patients
with cured colorectal cancer have been admitted for some
other reasons (eg, hip fracture) with no need for palliative
care. The large numbers of our patients minimize the
possible effect of this limitation in terms of the main
findings.
In conclusion, this study, using ten-year data from the
NIS database, shed light on palliative care usage and lifesustaining and local procedures in overall colorectal cancer
patients in US hospitals. Palliative care has been increasingly
offered to patients with colorectal cancer in inpatient care
settings, but it still is underutilized. Palliative care usage was
inversely associated with life-sustaining and local proce
dures. Further studies are warranted to clarify the utilization
of these services in subgroups of cancer patients in advanced
stages.
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